AVITA MEDICAL, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$18M
↓-4.3% -$791Kvs FY2024 (Q4)
Gross Profit
$14M
↓-11.3% -$2Mvs FY2024 (Q4)
Operating Income
$8M
↓-27.3% -$3Mvs FY2024 (Q4)
Net Income
$7M
↓-30.4% -$3Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $18M | $18M |
| COGS | $3M | $2M |
| Gross Profit | $14M | $16M |
| R&D | $6M | $5M |
| SG&A | $0 | $0 |
| D&A | $700K | $409K |
| Other OpEx | $20K | $0 |
| Operating Income | $8M | $11M |
| Interest Exp. | $1M | $1M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $7M | $10M |
| Tax | $0 | $19K |
| Net Income | $7M | $10M |
QuarterCharts · SEC EDGAR data · RCEL · Comparing FY2025 (Q4) vs FY2024 (Q4)